Search filters

List of works by Ofri Mosenzon

Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents -Post-hoc Analyses from DECLARE-TIMI 58

scientific article published on 26 August 2020

Cardiovascular and renal outcomes by baseline albuminuria status and renal function - results from the LEADER randomized trial

scientific article published on 03 July 2020

Positioning sulfonylureas in a modern treatment algorithm for patients with type 2 diabetes: expert opinion from a European Consensus Panel

scientific article published on 01 June 2020

The cost-effectiveness of dapagliflozin in treating high risk patients with type 2 diabetes mellitus: an economic evaluation using data from the DECLARE-TIMI 58 trial

scientific article published on 28 December 2020

Paulina is supported by:

About Paulina

Help